These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 18827564)
1. Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts. Labussière M; Aarnink A; Pinel S; Taillandier L; Escanyé JM; Barberi-Heyob M; Bernier-Chastagner V; Plénat F; Chastagner P Anticancer Drugs; 2008 Nov; 19(10):991-8. PubMed ID: 18827564 [TBL] [Abstract][Full Text] [Related]
2. Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts. Chastagner P; Sudour H; Mriouah J; Barberi-Heyob M; Bernier-Chastagner V; Pinel S Pharm Res; 2015 Jan; 32(1):158-66. PubMed ID: 25048636 [TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts. Labussiere M; Pinel S; Delfortrie S; Plenat F; Chastagner P Oncol Rep; 2008 Nov; 20(5):1283-7. PubMed ID: 18949434 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922 [TBL] [Abstract][Full Text] [Related]
5. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates. Takahashi H; Adachi K; Yamaguchi F; Teramoto A Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367 [TBL] [Abstract][Full Text] [Related]
6. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
8. [Antitumor efficacy of FK 973 on malignant glioma cells]. Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model. Kim HM; Kang JS; Lim J; Kim JY; Kim YJ; Lee SJ; Song S; Hong JT; Kim Y; Han SB Arch Pharm Res; 2009 May; 32(5):781-7. PubMed ID: 19471894 [TBL] [Abstract][Full Text] [Related]
10. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410 [TBL] [Abstract][Full Text] [Related]
11. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128 [TBL] [Abstract][Full Text] [Related]
12. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
13. [The radiation therapy of experimental brain tumors by using the radiosensitizing preparation xanthobin (8-bromocaffeine)]. Vartanian LP; Rudenko IIa; Volchkov VA Med Radiol (Mosk); 1989 Nov; 34(11):82-3. PubMed ID: 2586265 [No Abstract] [Full Text] [Related]
14. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; Muolo M; D'Amore E; Maraviglia B; Lazzarino G; Pastore FS Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S34-6. PubMed ID: 19375337 [TBL] [Abstract][Full Text] [Related]
15. Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Hau P; Dietrich J; Fabel K; Bogdahn U Expert Rev Neurother; 2002 Sep; 2(5):609-15. PubMed ID: 19810975 [TBL] [Abstract][Full Text] [Related]
16. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
17. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin. Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847 [TBL] [Abstract][Full Text] [Related]
19. Prolonged carotid arterial radiosensitizer infusion and radiation therapy of mouse gliomas. Goffinet DR; Brown JM; Bagshaw MA; Kaplan HS Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):7-15. PubMed ID: 4257891 [No Abstract] [Full Text] [Related]
20. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Lamfers M; Idema S; van Milligen F; Schouten T; van der Valk P; Vandertop P; Dirven C; Noske D Cancer Lett; 2009 Feb; 274(1):78-87. PubMed ID: 18842332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]